Article
Aberrant regulation of the MRP3 gene in non-small cell lung carcinoma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Jan 2012
Mahaffey Christopher M, Mahaffey Nichole C, Holland William, Zhang Hongqiao, Gandara David R, Mack Philip C, Forman Henry Jay
Abstract excerpt
INTRODUCTION: Multidrug-resistant protein-3 (MRP3), a membrane-bound transporter, facilitates efflux of toxic compounds, including certain chemotherapies, out of cells. Aberrant MRP3 expression has been linked to drug resistance in non-small cell lung carcinoma (NSCLC). We sought to determine if tumor MRP3 expression patterns correlate with the mutational status of upstream regulators, including nuclear factor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
